225 related articles for article (PubMed ID: 34183219)
1. Barriers and enablers of older adults initiating a deprescribing conversation.
Ailabouni NJ; Rebecca Weir K; Reeve E; Turner JT; Wilson Norton J; Gray SL
Patient Educ Couns; 2022 Mar; 105(3):615-624. PubMed ID: 34183219
[TBL] [Abstract][Full Text] [Related]
2. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
Evrard P; Pétein C; Beuscart JB; Spinewine A
Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
[TBL] [Abstract][Full Text] [Related]
3. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
Alharthi M; Wright D; Scott S; Birt L
Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
[TBL] [Abstract][Full Text] [Related]
4. Barriers and Enablers for Deprescribing Glucose-Lowering Treatment in Older Adults: A Systematic Review.
Mellot M; Jawal L; Morel T; Fournier JP; Tubach F; Cadwallader JS; Christiaens A; Zerah L
J Am Med Dir Assoc; 2024 Mar; 25(3):439-447.e18. PubMed ID: 38237904
[TBL] [Abstract][Full Text] [Related]
5. Barriers and enablers to deprescribing of older adults and their caregivers: a systematic review and meta-synthesis.
Bolt J; Abdoulrezzak R; Inglis C
Eur Geriatr Med; 2023 Dec; 14(6):1211-1222. PubMed ID: 37874489
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
[TBL] [Abstract][Full Text] [Related]
7. Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study.
Abou J; Crutzen S; Tromp V; Heringa M; Van Marum R; Elders P; Taxis K; Denig P; Hugtenburg J
Drugs Aging; 2022 Mar; 39(3):209-221. PubMed ID: 35187614
[TBL] [Abstract][Full Text] [Related]
8. Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study.
Antonelli MT; Cox JS; Saphirak C; Gurwitz JH; Singh S; Mazor KM
Ther Adv Drug Saf; 2022; 13():20420986221118143. PubMed ID: 36052398
[TBL] [Abstract][Full Text] [Related]
9. Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.
Tangiisuran B; Rajendran V; Sha'aban A; Daud NAA; Nawi SNM
Int J Clin Pharm; 2022 Feb; 44(1):201-213. PubMed ID: 34642869
[TBL] [Abstract][Full Text] [Related]
10. Considerations, barriers and enablers of deprescribing among healthcare professionals in Ogun State, Southwest, Nigeria: a cross-sectional survey.
Saka SA; Osineye TR
BMC Health Serv Res; 2024 May; 24(1):661. PubMed ID: 38789975
[TBL] [Abstract][Full Text] [Related]
11. Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS).
Kim JL; Lewallen KM; Hollingsworth EK; Shah AS; Simmons SF; Vasilevskis EE
Gerontologist; 2023 Mar; 63(3):523-533. PubMed ID: 35881109
[TBL] [Abstract][Full Text] [Related]
12. Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland.
Heinrich CH; McHugh S; McCarthy S; Donovan MD
PLoS One; 2022; 17(12):e0274552. PubMed ID: 36520798
[TBL] [Abstract][Full Text] [Related]
13. Barriers and enablers to deprescribing in long-term care facilities: a 'best-fit' framework synthesis of the qualitative evidence.
Heinrich CH; Hurley E; McCarthy S; McHugh S; Donovan MD
Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35077555
[TBL] [Abstract][Full Text] [Related]
14. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists.
Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D
Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097
[TBL] [Abstract][Full Text] [Related]
15. Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.
Anderson TS; Wang BX; Lindenberg JH; Herzig SJ; Berens DM; Schonberg MA
JAMA Netw Open; 2024 Mar; 7(3):e241342. PubMed ID: 38446478
[TBL] [Abstract][Full Text] [Related]
16. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
[TBL] [Abstract][Full Text] [Related]
17. Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.
Alwidyan T; McCorry NK; Parsons C
Int J Pharm Pract; 2023 May; 31(3):305-313. PubMed ID: 36866441
[TBL] [Abstract][Full Text] [Related]
18. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
[TBL] [Abstract][Full Text] [Related]
19. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.
Reeve E; Low LF; Hilmer SN
Br J Gen Pract; 2016 Aug; 66(649):e552-60. PubMed ID: 27266865
[TBL] [Abstract][Full Text] [Related]
20. Patient and Physician Perspectives of Deprescribing Potentially Inappropriate Medications in Older Adults with a History of Falls: a Qualitative Study.
Hahn EE; Munoz-Plaza CE; Lee EA; Luong TQ; Mittman BS; Kanter MH; Singh H; Danforth KN
J Gen Intern Med; 2021 Oct; 36(10):3015-3022. PubMed ID: 33469744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
